Use of population health data to refine diagnostic decision-making for pertussis

Andrew M Fine1, Ben Y Reis, Lise E Nigrovic

  • 1Division of Emergency Medicine, Children's Hospital Boston and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115, USA. andrew.fine@childrens.harvard.edu

Insights

A new decision model combining clinical data and local pertussis (whooping cough) incidence significantly improved case identification in infants. This approach enhances public health surveillance and clinical decision-making for pertussis.

Area of Science:

  • Infectious Disease Epidemiology
  • Clinical Decision Support Systems
  • Public Health Surveillance

Background:

  • Accurate identification of pertussis (whooping cough) is crucial for timely treatment and public health interventions.
  • Traditional diagnostic models often rely solely on clinical data, which can have limitations in sensitivity and specificity.
  • Integrating real-time, local disease incidence data can potentially enhance the accuracy of diagnostic models.

Purpose of the Study:

  • To develop and evaluate a decision model for identifying pertussis cases in infants.
  • To assess the added value of incorporating recent, local, population-level pertussis incidence data into a clinical decision model.
  • To compare the performance of models based on clinical data alone, incidence data alone, and a combination of both.

Main Methods:

  • Retrospective cohort analysis of 443 infants tested for pertussis between 2003 and 2007.
  • Development of three predictive models: clinical data only, local incidence data only, and combined clinical and incidence data.
  • Model performance was evaluated using sensitivity, specificity, and area under the receiver-operating characteristics (ROC) curve (AUC).

Main Results:

  • The clinical data-only model achieved 89% sensitivity and 27% specificity (AUC 0.80).
  • The local incidence-only model performed best when regional pertussis positivity exceeded 10%, yielding 13% sensitivity and 53% specificity (AUC 0.65).
  • The combined model, incorporating clinical variables (cyanosis, cough, absence of fever) and local incidence data, demonstrated superior performance with 100% sensitivity and 38% specificity (AUC 0.82).

Conclusions:

  • Incorporating recent, local population-level pertussis incidence significantly improves the accuracy of decision models for identifying infant pertussis cases.
  • The findings support enhanced collaboration between public health agencies and clinical practice.
  • This study validates a method for integrating large-scale public health data with clinical information to enhance diagnostic capabilities and public health outcomes.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...